Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Anti-obesity drugs
Robert F. Kushner
*
*
Corresponding author for this work
Medicine, Endocrinology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
17
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anti-obesity drugs'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Central Nervous System
100%
Combination Therapy
100%
Anti-obesity
100%
Health Professionals
50%
Satiety
50%
Pharmacological Agents
50%
Adjunctive Therapy
50%
Metabolic Control
50%
Phase II Trial
50%
Gastrointestinal
50%
Hormonal Signaling
50%
Energy Expenditure
50%
Weight Loss
50%
Control System
50%
Neuronal Network
50%
Monotherapy
50%
Genetic Control
50%
Patients with Obesity
50%
Medical Literature
50%
Nervous-peripheral
50%
Appetite Regulation
50%
Medicine and Dentistry
Combination Therapy
100%
Central Nervous System
100%
Antiobesity Drugs
100%
Satiety
50%
Drug Therapy
50%
Monotherapy
50%
Food Intake
50%
Body Weight
50%
Patient with Obesity
50%
Anti-Obesity Medication
50%
Energy Expenditure
50%
Nursing and Health Professions
Combination Therapy
100%
Drug Therapy
100%
Antiobesity Drugs
100%
Health Practitioner
50%
Patient with Obesity
50%
Body Weight
50%
Control System
50%
Monotherapy
50%
Neuroscience
Central Nervous System
100%
Antiobesity Drugs
100%
Satiety
50%
Energy Expenditure
50%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Antiobesity Drugs
100%
Monotherapy
50%